Kiwi, that's a statement I can definitely get behind. It makes sense the drugs would be complimentary. Heck, VIP being naturally occurring in the body will probably get along with most drugs. Obviously blood pressure would have to be closely monitored.
An additional thought I wanted to share with you that I saw on another board... In thinking about the ramp up in production estimate being 150,000 in January might make sense if there is a plan to announce how effective Aviptadil is in treating Covid-19. The powers that be might not want everyone to completely change their approach to corona regarding mask wearing, social distancing, etc. If everyone went right back to normal there would probably be a huge spike in cases and hospitalizations. This is especially true if a vaccine has yet to roll out. So maybe they are slow playing this aspect so there is enough available for the anticipated number of cases? Anyway, just a thought.
JTORRENCE, I do not have a link. It was posted here and on another board from viewers that watched today's conference. Sorry. You can look back through today's posts for the discussion. Hopefully, the company will get something out soon to follow-up on the comments. This one is important.
News 
Market Data 
Discover 
